8-K: Clarivate Reports Mixed Q1 2025 Results; Reaffirms Full-Year Outlook

Clarivate Plc reports a slight decrease in total revenue for Q1 2025, but reaffirms its 2025 outlook, citing accelerated recurring organic revenue growth and strategic share repurchases.

Summary

• Clarivate Plc reported its first quarter 2025 results on April 29, 2025.
• Total revenues for Q1 2025 were $593.7 million, a decrease of 4.4% compared to $621.2 million in Q1 2024.
• Organic revenues increased slightly by 0.3%.
• The company reported a net loss of $103.9 million, or $0.15 per diluted share, compared to a net loss of $75.0 million, or $0.14 per diluted share, in the same quarter last year.
• Adjusted EBITDA was $233.2 million, down from $236.3 million in Q1 2024.
• Clarivate generated $171.2 million in operating cash flow and $110.3 million in free cash flow.
• The company repurchased $50 million of its ordinary shares during the quarter.
• Clarivate reaffirmed its full-year 2025 outlook, expecting revenues between $2.28 billion and $2.40 billion and adjusted EBITDA between $940 million and $1.00 billion.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue and profit metrics are down, the company is reaffirming guidance and executing share repurchases, indicating confidence in the future.

Positives

• Organic revenues showed a slight increase of 0.3%.
• Organic recurring revenues increased by 0.6%.
• The company generated $110.3 million in free cash flow.
• Clarivate repurchased $50 million of its ordinary shares.
• The company reaffirmed its full-year 2025 outlook.
• Adjusted EBITDA margin accelerated by 130 basis points.
• The business returned to modest organic growth in the first quarter.

Negatives

• Total revenues decreased by 4.4% to $593.7 million.
• Net loss increased to $103.9 million, or $0.15 per diluted share.
• Adjusted EBITDA decreased to $233.2 million.
• Subscription revenues decreased $14.5 million, or 3.6%, to $388.6 million, primarily due to the ScholarOne product group divestiture.
• Free cash flow for the three months ended March 31, 2025 was $110.3 million, a decrease of $1.5 million compared to the prior year period.

Risks

• The company's performance is subject to risks and uncertainties described in its annual report on Form 10-K.
• Foreign currency translation impacts negatively affected revenue.
• The company faces risks related to the volatile macro environment.
• The company's future results could be affected by restructuring costs associated with the Value Creation Plan.

Future Outlook

Clarivate reaffirms its full-year 2025 outlook, expecting revenues between $2.28 billion and $2.40 billion, adjusted EBITDA between $940 million and $1.00 billion, and free cash flow between $300 million and $380 million.

Management Comments

• Matti Shem Tov, Chief Executive Officer, stated that the company delivered improved sequential organic ACV growth in the first quarter.
• Matti Shem Tov said that Clarivate's offerings are mission-critical and competitively advantaged, enabling a successful transition to a subscription-first strategy.
• Jonathan Collins, Executive Vice President and Chief Financial Officer, noted the business returned to modest organic growth and Adjusted EBITDA margin accelerated by 130 basis points.
• Jonathan Collins stated that the company generated strong free cash flow and repurchased $50 million of shares, consistent with their capital allocation strategy.

Industry Context

Clarivate operates in the transformative intelligence industry, providing data, insights, and analytics to academia, government, intellectual property, and life sciences sectors. The company's performance is influenced by trends in research funding, patent activity, and healthcare innovation.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without knowing Clarivate's specific peer group.
• However, companies like RELX Group (Reed Elsevier), Wolters Kluwer, and Thomson Reuters are comparable in terms of providing information and analytics.
• Clarivate's organic revenue growth of 0.3% is relatively modest; some peers may be experiencing higher growth rates in specific segments.
• The adjusted EBITDA margin of 39.3% is a key metric to compare against these peers to assess profitability.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and the increased net loss.
• The share repurchase program aims to return value to shareholders.
• Employees may be affected by restructuring costs associated with the Value Creation Plan.
• Customers should see improvements from the company's investments in product innovation.

Next Steps

• Clarivate will host a conference call and webcast to review the results for the first quarter.
• The company will continue to execute its Value Creation Plan.
• Clarivate will continue to monitor the volatile macro environment.

Key Dates

Keywords

Clarivate, financial results, Q1 2025, revenue, EBITDA, organic growth, free cash flow, outlook, share repurchase